PHARMARON (03759) has a current Price-to-Book (P/B) ratio of 2.26. Compared to its 3-year average P/B ratio of 2.10, the current P/B ratio is approximately 7.50% higher. Relative to its 5-year average P/B ratio of 4.58, the current P/B ratio is about -50.59% higher. PHARMARON (03759) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 0.38%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 0.10%, the current FCF yield is about -100.00% lower.

Performance Decomposition

AI Analysis

Market capitalization of 03759 increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of 03759 in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is 03759 currently overvalued or undervalued?

What is PHARMARON (03759) fair value?

03759's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of PHARMARON (03759) is between to according to relative valuation method.

How does 03759's valuation metrics compare to the industry average?

The average P/S ratio for 03759's competitors is 0.00, providing a benchmark for relative valuation. PHARMARON Corp (03759) exhibits a P/S ratio of --, which is 0% above the industry average. Given its robust revenue growth of 0%, this premium appears unsustainable.

What is the current P/B ratio for PHARMARON (03759) as of Mar 02 2026?

As of Mar 02 2026, PHARMARON (03759) has a P/B ratio of 2.26. This indicates that the market values 03759 at 2.26 times its book value.

What is the current FCF Yield for PHARMARON (03759) as of Mar 02 2026?

As of Mar 02 2026, PHARMARON (03759) has a FCF Yield of 0.00%. This means that for every dollar of PHARMARON's market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for PHARMARON (03759) as of Mar 02 2026?

As of Mar 02 2026, PHARMARON (03759) has a Forward P/E ratio of 15.11. This means the market is willing to pay $15.11 for every dollar of PHARMARON's expected earnings over the next 12 months.

What is the current Forward P/S ratio for PHARMARON (03759) as of Mar 02 2026?

As of Mar 02 2026, PHARMARON (03759) has a Forward P/S ratio of 0.00. This means the market is valuing 03759 at $0.00 for every dollar of expected revenue over the next 12 months.

03759 Valuation